Articles On LBT Innovations (ASX:LBT)

ADELAIDE, Australia, Sept. 27, 2021 /PRNewswire/ — Australian medical technology company LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to anno...

Highlights Artificial intelligence (AI) forms a part of emerging technologies that are expected to shape the future in the upcoming years. The COVID-19 pandemic pushed a significant growth in the AI adoption by many companies. LBT,...

ShareCafeHidden Gems Webinar Recap – Perpetual, OLL, FCT, LBT & MX1 Catch up on the full webinar with a keynote presentation from Perpetual & presentations from OpenLearning (ASX: OLL), First Wave Cloud Technology (ASX: FCT), LBT I...

ShareCafeDisrupting the clinical microbiology market through AI Brent Barnes – CEO and Managing Director – LBT Innovations is a groundbreaking designer of advanced technology solutions for the medical industry. Disrupting the clinical micr...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Highlights  ASX-listed healthcare companies rarely fail to bring joy to the market participants, with a few of them providing outstanding returns in the last couple of months. Rhinomed, IDT Australia, and Prescient lead the way with ou...

Another red day for the ASX to close out the week. The ASX 200 closed 0.05% down from yesterday at 7,461 points, 2.2% lower than a week ago. The ASX Emerging Companies Index meanwhile dropped 2.09%, closing at 2,187 points which is over 5%...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the le...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Closing Bell is Stockhead’s daily recap of the trading day on the ASX covering the overall direction of the market, biggest winners and losers as well as other news you might’ve missed during the trading day. Today, ASX shareholders were ta...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

A series of ASX announcements has attracted investors to the biotech sector today, lifting the share prices of some of its players. The buying frenzy has also lifted the broader health sector by as high as 1 per cent earlier today, but is c...

LBT Innovations (ASX:LBT) shares rose this morning after it sold its first two pathology sample analysers in the UK. LBT’s APAS Independence (Automated Plate Assessment System) sorts medical samples and uses AI and machine learning to deter...

Australia’s digital and technology sector got a major boost in last night’s Federal Budget, with the government announcing a total of $1.2 billion spending for the whole sector. Part of that, or around 10 per cent, will be used to support t...

ShareCafeHidden Gems Webinar Recap – DNR Capital, 1AG, LBT, PLT, NVU  Catch up on the full webinar with a keynote presentation from DNR Capital & presentations from Alterra Limited (ASX:1AG), LBT innovations (ASX:LBT) , Plenti Group Li...

ShareCafeLBT Innovations (ASX:LBT) – Hidden Gems Webinar Presentation Presenter – Brent Barnes – CEO & Managing Director – ​LBT Innovations is a designer of advanced technology solutions for the medical industry. The company specialize...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Adelaide-based minnow LBT Innovations is ready to sell its automated agar plate interpretation device to the world – or, more ... Read More The post Dr Boreham’s Crucible: LBT Innovations has one product – but at least it’s on the market ap...

Australian medical technology company LBT Innovations (ASX:LBT) has announced the sale of an APAS Independence with MRSA analysis module to the Limbach Group based in Germany.

AI-based biotechnology company LBT Innovations has landed a sale in Europe for its APAS Independence platform. ... Read More The post LBT Innovations lands European sales deal for AI-based laboratory tech appeared first on Stockhead.

ShareCafeLBT Innovations – Hidden Gems Webinar Presentation   Presenter – Brent Barnes – CEO & MD – LBT Innovations improves patient outcomes by making healthcare more efficient. Based in Adelaide, South Australia, the Company has a hi...

ShareCafeHidden Gems Webinar Recap – LBT, ADN, NYR, SPT   Catch up on the full webinar with presentations from LBT Innovations Ltd (ASX:LBT), Andromeda Metals Ltd (ASX:ADN), Nyrada Inc (ASX: NYR) and Splitit Ltd (ASX:SPT). Hidden Gems Webi...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week We’re coming...

ASX companies continued to raise money in July, with over $4bn shelled out by investors, taking 2020’s total above $30bn. According to Bloomberg, there has been $32.3bn worth of cash raised between January 1 and August 3. This is well ahead...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The market...

A month away from hitting the ASX, 4DMedical has its sights set on the United States and its spiralling COVID-19 situation as a target market for its lung imaging technology. The Australian medtech is developing a patented X-ray imaging pla...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The life s...

ASX-listed biotech LBT Innovations has inked an agreement with an American medical testing company - and now wants fresh funds to help make the most of it. 

Fresh off its first sale in the US and positive results from a John Hopkins School of Medicine study, LBT Innovations (ASX:LBT) shares are set to rise again following a European marketing deal. The Adelaide company makes automated microbiol...

Australian medical technology company LBT Innovations (ASX: LBT) has signed a marketing agreement with clinical diagnostics specialist Beckman Coulter for the sale of its culture-plate screening and interpretation technology throughout Euro...

A quick wrap of the key winners and losers on Wednesday, July 1. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 874 stocks rose, 463 declined and 776 wer...

The LBT Innovations Limited (ASX: LBT) share price is storming higher today after the company announced the achievement of a milestone in the United States. At the time of writing, LBT Innovations shares last changed hands at 15.5 cents, r...

Australian medical technology company LBT Innovations (ASX:LBT) has updated investors on its 510(k) submission to the US FDA for the APAS Independence with MRSA analysis module.

Australian medical technology company LBT Innovations (ASX LBT) has announced the submission of a 510(k) application to the US FDA for the APAS Independence inclusive with the MRSA analysis module as a Class 2 medical device.

Technology with excellent innovation potential is Artificial Intelligence (AI), which is gaining ubiquitous applicability in multiple industries like a flash. Lately, Innovation and Science Australia (ISA) also recommended prioritising inve...

Here’s our fortnightly wrap of the major small cap health stock winners and losers.  One small cap ASX healthcare company has stormed home to top the tables at the end of October. Novita Healthcare (ASX:NHL) shares have exploded 500 per cen...

LBT Innovations Limited (ASX: LBT)- the Australian medical technology company secured its first sales for its APAS® Independence instrument in the European Union. The company sold the APAS® Independence instrument to Labor Dr Wisplinghoff...

Australian medical technology company LBT Innovations (ASX: LBT) has announced the first sale of its APAS (Automatic Plate Assessment System) Independence instrument within the European Union, to Germany’s largest clinical laboratory Labor...

The 10th Annual Australian Microcap Investment Conference will be held on Tuesday 22 October 2019 over two days at the Sofitel Melbourne on Collins. The Conference is Australia’s largest and most comprehensive emerging company investment ev...

Medical technology company LBT Innovations (ASX: LBT) is set to take its artificial intelligence-inspired APAS Independence instrument to Europe after obtaining the highly prized CE Mark certification – a stamp of regulatory approval issued...

The sales focus in Australia continues to be private-sector laboratories as public laboratories remain challenging with no new tenders expected in 2019.

A company may require more funds over and above its retained earnings in order to expand its existing operations, develop new businesses, protect market share or buy another company. The requirement of the company can be fulfilled by either...

At Stockhead we are as amazed as our readers when stocks rise by over 100 per cent in a day. But its a more common occurrence than we thought. There have been 23 stocks that have achieved that feat. The three most common reasons are success...

This second drawdown, together with the cash on hand following a recent $5 million placement, means the company is well funded into 2021.